Evidence map›Paper›PMID 36404819›Full record

ArticleJournal of diabetes and metabolic disorders2022

Metformin and alpha lipoic acid ameliorate hypothyroidism and its complications in adult male rats.

Noha M Khoder, Hussein G Sawie, Hayat M Sharada, Eman N Hosny, Yasser A Khadrawy, Mohga S Abdulla

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. The protective role of α-lipoic acid in hypothyroidism-related ovarian damage.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Noha M KhoderMedical Physiology Department, Medical Research and Clinical Studies Institute, National Research Centre, El-Bohouth St, Giza, Egypt.
Hussein G SawieMedical Physiology Department, Medical Research and Clinical Studies Institute, National Research Centre, El-Bohouth St, Giza, Egypt.
Hayat M SharadaChemistry Department, Faculty of Science, Helwan University, Cairo, Egypt.
Eman N HosnyMedical Physiology Department, Medical Research and Clinical Studies Institute, National Research Centre, El-Bohouth St, Giza, Egypt.
Yasser A KhadrawyMedical Physiology Department, Medical Research and Clinical Studies Institute, National Research Centre, El-Bohouth St, Giza, Egypt.ORCID 0000-0003-2562-535X
Mohga S AbdullaMedical Physiology Department, Medical Research and Clinical Studies Institute, National Research Centre, El-Bohouth St, Giza, Egypt.
National Research Centre · EGHelwan University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The current study evaluates the effect of metformin (MET) and /or alpha lipoic acid (ALA) on hypothyroidism and its adverse effects on the cardiac, renal, and, hepatic functions in rats. Materials and methods: Rats were divided into five groups: control, rat model of hypothyroidism induced by propylthiouracil (PTU), rat model of hypothyroidism treated with MET, rat model of hypothyroidism treated with ALA, and rat model of hypothyroidism treated with MET and ALA. At the end of the experiment, body weight gain was determined and the blood samples were collected from orbital plexus to measure the serum levels of thyroxine (T4), triiodothyronine (T3) and thyroid stimulating hormone (TSH) by ELISA, glucose level, the activities of lactate dehydrogenase (LDH), creatine kinase MB (CK-MB), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP), and the levels of urea and creatinine spectrophotometrically. Results: Rat model of hypothyroidism revealed a significant decrease in T4 (p Conclusion: The present findings indicate the ameliorative effects of MET and /or ALA on hypothyroidism and its adverse effects on cardiac, renal and hepatic functions. Graphical Abstract: Supplementary information: The online version contains supplementary material available at 10.1007/s40200-022-01063-7.

Indexed as

Alpha lipoic acidHypothyroidismLiver, kidney, heartMetformin

Identifiers

PMID36404819
PMCPMC9672160
OpenAlexW4281650870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.